Andere talen Cytosorbents Corporation

Aandelen

CTSO

US23283X2062

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,7977 ^USD	-7,97%		-18,59%	-28,14%

15/03	Cytosorbents Corporation rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023	CI
14/03	Transcript : Cytosorbents Corporation, Q4 2023 Earnings Call, Mar 14, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M	14/03
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results	14/03
CytoSorbents to Report Fiscal 2023 Operating and Financial Results	06/03
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	08/02
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	08/02
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	31/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	23/01
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	17/01
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	17/01
Cytosorbents Corporation Reports Excellent Outcomes from A Groundbreaking Randomized Controlled Trial Using Cytosorb® Blood Purification During Heart Transplant, Recently Published in the European Society of Cardiology Journal, Esc Heart Failure	17/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	14/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	06/01
North American Morning Briefing : Stock Futures Struggle After Weak China Data	02/01
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	29/12
S&P 500 ekes out meager gains, flirts with bull market confirmation	28/12
Sector Update: Health Care Stocks Rise in Late Afternoon	28/12
Top Midday Decliners	28/12
Wall St inches higher as S&P 500 flirts with bull market confirmation	28/12
US Stocks Holding on for Small Thursday Gains, Again Drifting Near Record Highs	28/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cytosorbents Corporation

Aandelen

CTSO

US23283X2062

Andere talen

Filters